Thorsten Lehr

[Thorsten Lehr @lehr_thorsten]

https://t.co/EbCqnXf6b5

[Thorsten Lehr @lehr_thorsten]

Been a while since I posted, but today’s a good reason. Our phase 2 RCT (CONTAIN) of an azelastine nasal spray for pre‑exposure prophylaxis is out in JAMA Internal Medicine. ~two‑thirds fewer SARS‑CoV‑2 infections vs placebo. Link below ⬇️ #JAMAIM #COVID19

[Thorsten Lehr @lehr_thorsten]

@EricTopol Thanks for sharing @EricTopol

[Marie von den Benken @Regendelfin]

Wir haben ihn als Steroide inhalierenden Muskelmann ohne Hirn verspottet.
Als er Gouverneur von Kalifornien wurde, haben wir ungläubig gekichert.

Spätestens heute wissen wir: Die Welt wäre besser, wenn Arnold Schwarzenegger US-Präsident werden dürfte.

[SafePolyMed @safepolymed]

💊How can tools transform the way we manage our drug plans? Joan Jordan shares her insightful story of medication management, emphasising the importance of staying organised for yourself and others.
✨Read more here
https://t.co/Ogqw3bpIlM

#DrugSafety #PatientSafety #SafePolyMed

[SafePolyMed @safepolymed]

Meet our 3rd #SafePolyMed advocate of the day: Tamika Lang from the @leukade's advisory committee. 👇

💊 This #WPSD23, get inspired to shape a safer future in drug treatment & read the full interview here:
https://t.co/1Xj8J39I2g

#PatientSafety #WorldPatientSafetyDay

[SafePolyMed @safepolymed]

Meet our 2nd #SafePolyMed advocate of the day: Jenny Camaradou from the @leukade's advisory committee. 👇

💊 This #WPSD23, get inspired to shape a safer future in drug treatment & read the full interview here:
https://t.co/1Xj8J39acI

#PatientSafety

[Research Square Covid-19 Preprints @RS_COVID19]

Motivations for Adolescent COVID-19 Vaccination: A Comparative Study of Adolescent and Caregiver Perspectives in Germany #covid https://t.co/vFVKgFmurW

[SafePolyMed @safepolymed]

🇬🇷 Truly energised after #SafePolyMed's 1st progress meeting in Athens! We got together to discuss work plans, tackle challenges, and explore how #ML could impact our research. Can't wait to keep contributing to #PatientSafety and meet again in Munich this Nov! #DrugSafety

[Thorsten Lehr @lehr_thorsten]

Proud and grateful 🙏that our recent research on #metformin is featured by @NatureRevEndo

[Nature Reviews Endocrinology @NatureRevEndo]

AOP #ResearchHighlight: A new study indicates that the pharmacokinetics of #metformin vary considerably over a day (£) https://t.co/HghDgjeloV
@deni_tue @ChrisDngs @onwhenrdy @R_Dallmann @lehr_thorsten @hanke_nina @Saar_Uni

[Thorsten Lehr @lehr_thorsten]

🔬New #Metformin research demonstrates fluctuating exposure levels throughout the day🌗. The clinical implications remain uncertain, but warrant further exploration🔍.

Kudos to our amazing team🌟: @deni_tue, @onwhenrdy, @ChrisDngs, @R_Dallmann, @hanke_nina, and more!

[Diabetologia @DiabetologiaJnl]

#Pharmacokinetic #modelling indicates that observed significant time-of-day variation in #pharmacokinetics of #metformin could be attributed to rhythms in passive and active #renal excretion. #PK #NLME #PBPK #T2DM https://t.co/QCupJlztor 🔓

[Diabetologia @DiabetologiaJnl]

#Pharmacokinetic #modelling indicates that observed significant time-of-day variation in #pharmacokinetics of #metformin could be attributed to rhythms in passive and active #renal excretion. #PK #NLME #PBPK #T2DM https://t.co/QCupJlztor 🔓

[SafePolyMed @safepolymed]

We're in the #TKspezial from @TK_Presse!

Our coordinator Thorsten Lehr sat down with Germany's largest health insurance company to talk about #PatientSafety and #SafePolyMed's goals:

💊💊https://t.co/z6sv63RhFg

Vielen Dank an Stefan Groh und sein Team @TKinSL!

[TK-Landesvertretung Saarland @TKinSL]

Wir haben heute unser neues #TKspezial verschickt. Diesmal beschäftigen wir uns mit dem Wert von #Gesundheitsdaten für die #Patientensicherheit. U.a. haben wir @lehr_thorsten zum Projekt #SafePolyMed interviewt. Klicken Sie doch mal rein. ^SG
https://t.co/i7cFy7IX7i

[SafePolyMed @safepolymed]

Brilliant results to build on in this @TheLancet article - co-authored among others by Prof Jesse J Swen (@LUMC_Leiden Lead in #SafePolyMed) and our coordinator Prof Thorsten Lehr @lehr_thorsten.

Here's the full text:
🔗https://t.co/6v9rQnnzHg

#DrugSafety #AdverseDrugReactions

[Thorsten Lehr @lehr_thorsten]

Exciting results from the #UPGx project 🥳 and an important milestone on the road towards a routine implementation of preemptive pharmacogenetic testing in clinical practice.

Looking forward to extend the approach in our @safepolymed project.

https://t.co/ZO48U7O6vz

[Geoffrey Supran @GeoffreySupran]

NEW: In @ScienceMagazine today, our latest peer-reviewed research shows Exxon scientists predicted global warming with shocking skill & accuracy between 1977 & 2003, contradicting the company's decades of climate denial. THREAD.

📰No pay wall for 2 weeks: https://t.co/JDtT9nkbzC

[SAFEST EU Project @safestsurgery]

Yesterday we met with other projects funded under the #HorizonEU topic Enhancing quality of care and patient safety @Deliverproject1 @safepolymed @BESAFE_HORIZON 🔗https://t.co/ZoWK8ZEnPo

We discussed team-building activities, knowledge-sharing, joint meetings, & publications!

[Eric Topol @EricTopol]

New US Covid genomics: BQ.1.1 and BQ.1 variants now account for 27% of cases, up from 17% a week ago, on a path to be dominant (>50%) in the weeks ahead
https://t.co/jjl2AnwOWX

[Eric Topol @EricTopol]

Important update of US genomic surveillance with noteworthy transition as BA.5 fades, BQ.1.1 quickly gains, along with other variants (BF.7, BA.2.75.2).
https://t.co/jjl2AnwOWX